Phoebe’s Story

Sky’s the Limit for Phoebe Thanks to MiSight® 1 day*

When Phoebe was diagnosed with myopia, her mom, Patty, knew she had to be proactive.

Patty was well acquainted with myopia because she had it herself. Diagnosed at a young age, Patty knew all the hardships. “I thought about my own journey with nearsightedness, and how my life was really affected growing up wearing glasses,” says Patty. So finding out that her daughter, Phoebe also suffered from nearsightedness filled Patty with lots of concerns.

Myopia is the result of the eyeball growing longer than it should, or the cornea being curved too steeply, causing blurry distance vision or nearsightedness. For many kids like Phoebe, that means struggling to see the whiteboard in class and to make out the ball while playing sports.

Phoebe followed in her mom’s footsteps and got eyeglasses to correct her vision, but Patty was still worried about Phoebe’s eye health. As myopia worsens, eye health conditions can occur later in life like glaucoma, cataracts, retinal detachment, and macular degeneration.1 So after learning that Phoebe’s myopia had progressed and was steadily getting worse, her doctor made a recommendation: MiSight® 1 day* contact lenses.

After doing her research, Phoebe’s mom was immediately won over by MiSight® 1 day contact lenses by CooperVision®. Crafted to correct distance vision immediately,2 MiSight® 1 day soft contact lenses are specifically designed for myopia control and are FDA approved* to slow the progression of myopia in children aged 8 – 12 at the initiation of treatment.†3

“The fact that they are daily disposable, and FDA approved* to slow the progression of myopia in children aged 8 – 12 at the initiation of treatment†3 – to me, that’s really exciting. It just makes MiSight® lenses the best choice for Phoebe.” Now, Phoebe can participate in activities without uncertainty or worry. She says, “I wear them for the whole day. I forget they’re even there, they’re so comfortable.”

For Patty, being proactive about Phoebe’s eye health was the only choice: “I refused to let myopia limit my child.” Knowing that there was something that could be done about Phoebe’s progressive myopia was a comfort to both mother and daughter.

As Phoebe puts it, “It was a happy feeling.”

Myopia Blog 

children wearing bike helmets

A Clear Path to Confidence: Research Shows Contact Lenses Can Help Elevate Self-Esteem for Kids 

As parents, we all want our children to feel confident and happy. One often-overlooked way to boost a child's self-esteem is through vision correction for myopia

girl wearing lacross helmet smiling (large)

The Winning Edge: How Contact Lenses Can Boost Young Athletes' Vision and Performance

Clear vision is essential for young athletes when it comes to their ability to perform in sports and their active lifestyles. 

My Child Has Myopia—Now What? 

First, it’s important that you do something. That may seem obvious, but it’s important to underscore here because that hasn’t always been the case with myopia.

Eye issues in children: How nearsightedness and blurry vision can affect your child

Your children’s vision helps them see the world, and it plays an important role in their development.1 Issues with your child’s vision can cause challenges in their life—at home, school,

Explore the Myopia Blog

Where can I learn more? 

Explore the channels below to learn more about patients’ experiences living with nearsightedness and more information to help you child be successful with wearing MiSight® 1 day.

By prescription only. Results may vary. Please reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information.

* INDICATIONS AND BRIEF SAFETY INFORMATION for MiSight® 1 day soft contact lens:
INDICATIONS:
MiSight® 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear is a prescription device indicated for the correction of nearsightedness and for slowing the progression of nearsightedness in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism
BRIEF SAFETY INFORMATION:
Rx only; results may vary.
ATTENTION: Reference Coopervision.com/misight/safety for a complete listing of Indications and Important Safety Information.
INDICATIONS: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
WARNINGS: Problems with contact lenses could result in serious injury to the eye. Do not expose contact lenses to water while wearing them. Under certain circumstances MiSight® lenses optical design can cause reduced image contrast/ghosting/halo/glare in some patients that may cause difficulty with certain visually-demanding tasks.
PRECAUTIONS: Daily wear single use only. Patient should always dispose when lenses are removed. No overnight wear. Patients should exercise extra care if performing potentially hazardous activities.
ADVERSE EVENTS: Including but not limited to infection/inflammation/ulceration/abrasion of the cornea, other parts of the eye or eyelids. Some of these adverse reactions can cause permanent or temporary loss of vision. If you notice any of the stated in your child, immediately have your child remove the lenses and contact your eye care professional.
‡‡ National rebate: *Available on purchases between 1/1/26-12/31/26. Must submit rebate form within 60 days of lens purchase.
 

References 

1 Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31:622-60. 
2 Rah, M.J., et al. Vision-specific quality of life of pediatric contact lens wearers. Optom Vis Sci (2010); 87(8):560-566.
3 Chamberlain, P., et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci (2019); 96(8):556-567.